Effects of angiotensin-converting enzyme inhibitors and β-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy

被引:39
作者
Zheng, Zhi
Chen, Haibing
Xu, Xun
Li, Chunxia
Gu, Qing
机构
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200080, Peoples R China
[2] Anhui Provincial Hosp, Dept Ophthalmol, Hefei, Peoples R China
[3] Shanghai Jiao Tong Univ, Affiliated People Hosp 6, Shanghai Diabet Inst, Shanghai, Peoples R China
[4] Shanghai Hosp Integrated Tradit Chinese & Western, Dept Ophthalmol, Shanghai, Peoples R China
关键词
angiotensin-converting enzyme inhibitor; beta-adrenergic blocker; hypertension; vascular endothelial growth factor; diabetic retinopathy;
D O I
10.1016/j.exer.2006.12.013
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Vascular endothelial growth factor (VEGF) plays a pivotal role in diabetic retinopathy (DR) and hypertension has been identified as an independent risk factor for DR. The aim of the present study was to: (1) explore whether beta-adrenergic blockers influence retinal VEGF expression; (2) determine the effect of angiotensin-converting enzyme inhibitors (ACEI) on retinal VEGF expression independently of their anti-hypertensive actions; and (3) investigate the correlation between retinal VEGF expression and changes in retinal capillary basement membrane thickness (BMT). Streptozotocin-induced diabetic rats and control animals were assigned at random to receive the beta-adrenergic blocker propranolol, the ACEI fosenopril sodium, or vehicle for 24 weeks. Enzyme linked immunosorbent assay, immunohistochemistry, Western blot, and real-time reverse transcription-polymerase chain reaction were used to assess VEGF protein and mRNA expression. Computer-assisted morphometric measurements of transmission electron microscopy photographs were performed to evaluate BMT. Vitreous fluid and retinal VEGF protein and retinal VEGF mRNA expression were significantly higher in diabetic rats than in control rats, with a significant reduction in fosenopril sodium-treated diabetic rats (p < 0.01). There was no significant difference in VEGF levels in diabetic rats and propranolol-treated diabetic rats (p > 0.05), but there was a significant difference in VEGF protein and mRNA expression in propranolol-treated diabetic rats and fosenopril sodium-treated diabetic rats (p < 0.01) without any significant difference in systolic blood pressure in the latter two groups (p > 0.05). There was a significant correlation between the level of retinal VEGF expression and changes in retinal BMT (p < 0.01). These findings suggest that the effect of ACEI on retinal VEGF expression is independent of their anti-hypertensive actions and that ACEI could offer particular benefits beyond blood pressure reduction in the treatment of DR with or without hypertension. beta-adrenergic blockers had no influence on retinal VEGF expression in normal or diabetic rats. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:745 / 752
页数:8
相关论文
共 43 条
  • [31] Retinopathy and vision loss in insulin dependent diabetes in Europe - The EURODIAB IDDM complications study
    Sjolie, AK
    Stephenson, J
    Aldington, S
    Kohner, E
    Janka, H
    Stevens, L
    Fuller, J
    [J]. OPHTHALMOLOGY, 1997, 104 (02) : 252 - 260
  • [32] SPOERRI PE, 1998, INT J DIABETES, V6, P15
  • [33] Srivastava B K, 2005, J Assoc Physicians India, V53, P803
  • [34] Stearne MR, 1998, BRIT MED J, V317, P713
  • [35] Stearne MR, 1998, BMJ-BRIT MED J, V317, P703
  • [36] Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 - Potential mechanisms for exacerbation of diabetic retinopathy by hypertension
    Suzuma, I
    Hata, Y
    Clermont, A
    Pokras, F
    Rook, SL
    Suzuma, K
    Feener, EP
    Aiello, LP
    [J]. DIABETES, 2001, 50 (02) : 444 - 454
  • [37] Determination of amino acids in rat vitreous perfusates by capillary electrophoresis
    Thongkhao-On, K
    Kottegoda, S
    Pulido, JS
    Shippy, SA
    [J]. ELECTROPHORESIS, 2004, 25 (17) : 2978 - 2984
  • [38] Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy
    van Buggenum, IMH
    Polak, BCP
    Reichert-Thoen, JWM
    de Vries-Knoppert, WAEJ
    van Hinsbergh, VWM
    Tangelder, GJ
    [J]. DIABETOLOGIA, 2002, 45 (02) : 203 - 209
  • [39] Norepinephrine upregulates vascular endothelial growth factor in rat cardiac myocytes by a paracrine mechanism
    Joachim Weil
    Ralf Benndorf
    Sabine Fredersdorf
    Daniel P. Griese
    Thomas Eschenhagen
    [J]. Angiogenesis, 2003, 6 (4) : 303 - 309
  • [40] Angiotensin and diabetic retinopathy
    Wilkinson-Berka, JL
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (5-6) : 752 - 765